Hypoxic-Ischemic Encephalopathy (HIE) Clinical Pathway — ICU
Hypoxic-Ischemic Encephalopathy (HIE) Clinical Pathway — ICU
Evidence
- Hypothermia and Neonatal Encephalopathy
- Cooling for Newborns with Hypoxic Ischaemic Encephalopathy
- Effect of Depth and Duration of Cooling on Deaths in the NICU Among Neonates With Hypoxic Ischemic Encephalopathy
- Effect of Depth and Duration of Cooling on Death or Disability at Age 18 Months Among Neonates With Hypoxic-Ischemic Encephalopathy
- The Frequency and Severity of MRI Abnormalities in Infants with Mild Neonatal Encephalopathy
- MRI as a Biomarker for Mild Neonatal Encephalopathy
- Treating EEG Seizures in Hypoxic Ischemic Encephalopathy: A Randomized Controlled Trial
- Adverse Neurodevelopmental Outcomes after Exposure to Phenobarbital and Levetiracetam for the Treatment of Neonatal Seizures
- HEAL: High-dose EPO for Asphyxia and Encephalopathy
EEG
- Early Electroencephalogram Background Could Guide Tailored Duration of Monitoring for Neonatal Encephalopathy Treated with Therapeutic Hypothermia
- Seizure Burden and Neurodevelopmental Outcome in Newborns with Hypoxic-ischemic Encephalopathy Treated with Therapeutic Hypothermia: A Single Center Observational Study
- Association Between Increased Seizures During Rewarming After Hypothermia for Neonatal Hypoxic Ischemic Encephalopathy and Abnormal Neurodevelopmental Outcomes at 2-Year Follow-up
- The American Clinical Neurophysiology Society's Guideline on Continuous Electroencephalography Monitoring in Neonatesp
- American Clinical Neurophysiology Society Standardized EEG Terminology and Categorization for the Description of Continuous EEG Monitoring in Neonates
Imaging
- Neuroimaging in the Term Newborn with Neonatal Encephalopathy
- How Well Does Neonatal Neuroimaging Correlate with Neurodevelopmental Outcomes in Infants with Hypoxic-ischemic Encephalopathy?
- Impact of Therapeutic Hypothermia on MRI Diffusion Changes in Neonatal Encephalopathy
- Impact of Therapeutic Hypothermia on MRI Diffusion Changes in Neonatal Encephalopathy
- Integrating Neuroimaging Biomarkers Into the Multicentre, High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) Trial: Rationale, Protocol and Harmonisation